Roche, Novartis and the other Swiss pharma companies brought in CHF2.1 billion ($2.3 billion) from the export of pharmaceuticals to Russia in 2022.
In 2021 the Swiss pharma industry sold drugs worth CHF1.5 billion to Russia. This means sales increased by 40% since Russia invaded Ukraine. This is based on an analysis by the Swiss News Agency Keystone-SDA of foreign trade data released by the Swiss customs office on Tuesday.